Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone added to methotrexate for lichen planopilaris
IRCT20230415057912N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- May 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of pioglitazone and methotrexate in lichen planopilaris (LPP) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Photography scoring score, LPPAI and 2 more. Started May 2023; status: completed.
02
Drugs
pioglitazonemethotrexate
03
Conditions
lichen planopilaris (LPP)
Beyond the preview
Go deeper on IRCT20230415057912N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230415057912N1.